B. clausii is an aerobic, spore-forming bacterium that can survive transit through the acidic environment of the stomach and colonize the intestine even in the presence of antibiotics. It is a probiotic widely used in Italy since 1960s for viral diarrhea in children and for antibiotic associated diarrhea. It has been identified by name in 1995 by German bacteriologist Dieter Claus.
B. clausii is a spore forming probiotic highly stable in low gastric pH making it a very resilient, stable probiotic which can be stored at room temperature. B. clausii has the unique function of being a powerful supplement that can be used in adjunct with antibiotic therapy to keep the organisms balanced in the gut. It has proven to be an effective probiotic in the treatment of diarrhea and prevention of antibiotic associated diarrhea.
The strain of Bacillus clausii SC109® is manufactured by Synergia Life Sciences Pvt Ltd. SC109® is well researched, studied and documented by Dr. Simon Cutting.
